Related Experiment Videos
[Immunotherapy using the nasal route in bronchial asthma]
Revista Alergia Mexico
|May 1, 1989
Summary
This study found that four years of nasal drop immunotherapy significantly improved asthma symptoms in over 90% of patients. The treatment was effective for allergic rhinitis and associated conditions.
Area of Science:
- Allergy and Immunology
- Respiratory Medicine
- Clinical Research
Context:
- The study involved 1124 asthma patients with co-occurring allergic conditions like dermatitis and rhinitis.
- Patients were recruited from various health centers and outpatient services, including a major hospital.
- Standard laboratory and specific immunoallergologic tests were conducted.
Purpose:
- To evaluate the efficacy of a four-year immunotherapy regimen for asthma.
- To assess the impact of immunotherapy on associated allergic conditions.
- To determine patient outcomes and response rates to nasal drop immunotherapy.
Summary:
- A cohort of 1124 asthmatic patients underwent a four-year immunotherapy program using nasal drops.
- The immunoallergologic study included standard allergy testing with various extracts.
- Outcomes revealed significant improvement in 91% of patients, fair improvement in 6%, and no improvement in 2.2%.
Impact:
- Demonstrates the long-term effectiveness of nasal immunotherapy for asthma management.
- Highlights the potential for immunotherapy to address multiple allergic conditions simultaneously.
- Provides evidence-based recommendations for asthma treatment strategies.